irinotecan hydrochloride [clinicaltrials_resource:a9f3096d94cb9d1931650ce3b15d66a5]
intervention [clinicaltrials_vocabulary:intervention]
irinotecan hydrochloride [clinicaltrials_resource:a9f3096d94cb9d1931650ce3b15d66a5]
Bio2RDF identifier
a9f3096d94cb9d1931650ce3b15d66a5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a9f3096d94cb9d1931650ce3b15d66a5
intervention desc [clinicaltrials_vocabulary:intervention-desc]
350 or 700 mg/m2 IV every 3 weeks
intervention name [clinicaltrials_vocabulary:intervention-name]
irinotecan hydrochloride
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:a9f3096d94cb9d1931650ce3b15d66a5
title
irinotecan hydrochloride
@en
type
label
irinotecan hydrochloride [clinicaltrials_resource:a9f3096d94cb9d1931650ce3b15d66a5]
@en